Massachusetts Financial Services Co. MA Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Massachusetts Financial Services Co. MA lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,075,163 shares of the medical equipment provider’s stock after selling 62,312 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Intuitive Surgical were worth $561,192,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Howard Capital Management Group LLC raised its stake in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the last quarter. Principal Financial Group Inc. grew its position in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares during the period. Benjamin Edwards Inc. increased its holdings in Intuitive Surgical by 148.7% in the third quarter. Benjamin Edwards Inc. now owns 13,673 shares of the medical equipment provider’s stock valued at $6,718,000 after buying an additional 8,176 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Intuitive Surgical by 1.4% in the third quarter. Janus Henderson Group PLC now owns 689,939 shares of the medical equipment provider’s stock worth $338,948,000 after acquiring an additional 9,727 shares during the period. Finally, Integrated Wealth Concepts LLC increased its holdings in Intuitive Surgical by 1.9% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 4,821 shares of the medical equipment provider’s stock worth $2,369,000 after acquiring an additional 90 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Trading Up 2.2 %

NASDAQ:ISRG opened at $507.05 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a fifty day moving average price of $550.11 and a 200 day moving average price of $532.84. The firm has a market cap of $180.60 billion, a PE ratio of 79.10, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.